Spectral Medical, Inc. engages in the development and commercialization of therapeutic treatment for septic shock. Its products include endotoxin activity assay diagnostic and polymyxin b-hemoperfusion therapeutic device. The company was founded on July 29, 1991 and is headquartered in Toronto, Canada.